References
- Cheng MH, Krieger JM, Kaynak B, et al. Impact of South African 501.V2 variant on SARS-CoV-2 spike infectivity and neutralization: a structure-based computational assessment 2021; [2021 Feb 2]: [2021.01.10.426143]. Available from: https://www.biorxiv.org/content/biorxiv/early/2021/01/11/2021.01.10.426143.full.pdf.
- Wibmer CK, Ayres F, Hermanus T, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma 2021 [2021 Feb 3]: [2021.01.18.427166]. Available from: https://www.biorxiv.org/content/biorxiv/early/2021/01/19/2021.01.18.427166.full.pdf.
- Wang P, Lihong L, Iketani S, et al. Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization 2021 [cited 2021 Feb 3]: [2021.01.25.428137]. Available from: https://www.biorxiv.org/content/biorxiv/early/2021/01/26/2021.01.25.428137.1.full.pdf.
- Greaney AJ, Loes AN, Crawford KH, et al. Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affects recognition by polyclonal human serum antibodies 2021. Available from: https://www.biorxiv.org/content/biorxiv/early/2021/01/04/2020.12.31.425021.full.pdf.
- Wu K, Werner AP, Moliva JI, et al. mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants 2021 [2021.01.25.427948]. Available from: https://www.biorxiv.org/content/biorxiv/early/2021/01/25/2021.01.25.427948.full.pdf.
- Xie X, Liu Y, Liu J, et al. Neutralization of spike 69/70 deletion, E484 K, and N501Y SARS-CoV-2 by BNT162b2 vaccine-elicited sera 2021 [cited 2021 Feb 3]: [2021.01.27.427998]. Available from: https://www.biorxiv.org/content/biorxiv/early/2021/01/27/2021.01.27.427998.full.pdf.
- Huang B, Dai L, Wang H, et al. Neutralization of SARS-CoV-2 VOC 501Y.V2 by human antisera elicited by both inactivated BBIBP-CorV and recombinant dimeric RBD ZF2001 vaccines 2021 [cited 2021 Feb 3]: [2021.02.01.429069]. Available from: https://www.biorxiv.org/content/biorxiv/early/2021/02/02/2021.02.01.429069.full.pdf.
- Lopez-Rincon A, Perez-Romero C, Tonda A, et al. Design of specific primer sets for the detection of B.1.1.7, B.1.351 and P.1 SARS-CoV-2 variants using deep learning 2021. Available from: https://www.biorxiv.org/content/biorxiv/early/2021/01/21/2021.01.20.427043.full.pdf.